Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 10.62
(1.63%)
CNY 10.62
(1.63%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.61 Billion CNY | -2.45% |
| 2022 | 2.67 Billion CNY | 10.17% |
| 2021 | 2.42 Billion CNY | 28.13% |
| 2020 | 1.89 Billion CNY | -25.11% |
| 2019 | 2.53 Billion CNY | 7.2% |
| 2018 | 2.36 Billion CNY | 20.23% |
| 2017 | 1.96 Billion CNY | 16.06% |
| 2016 | 1.69 Billion CNY | 7.27% |
| 2015 | 1.57 Billion CNY | 20.57% |
| 2014 | 1.3 Billion CNY | 20.04% |
| 2013 | 1.09 Billion CNY | 22.97% |
| 2012 | 886.43 Million CNY | 18.09% |
| 2011 | 750.64 Million CNY | 17.16% |
| 2010 | 640.71 Million CNY | 16.16% |
| 2009 | 551.6 Million CNY | 13.9% |
| 2008 | 484.3 Million CNY | 19.76% |
| 2007 | 404.4 Million CNY | 23.71% |
| 2006 | 326.89 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 543.65 Million CNY | -24.83% |
| 2024 Q2 | 723.24 Million CNY | 12.81% |
| 2024 Q1 | 641.12 Million CNY | 18.89% |
| 2023 Q4 | 539.27 Million CNY | -8.44% |
| 2023 Q1 | 746.76 Million CNY | 9.02% |
| 2023 FY | 2.61 Billion CNY | -2.45% |
| 2023 Q3 | 588.98 Million CNY | -19.92% |
| 2023 Q2 | 735.52 Million CNY | -1.51% |
| 2022 Q2 | 650.06 Million CNY | -3.81% |
| 2022 FY | 2.67 Billion CNY | 10.17% |
| 2022 Q1 | 675.79 Million CNY | 11.61% |
| 2022 Q4 | 684.94 Million CNY | 2.95% |
| 2022 Q3 | 665.34 Million CNY | 2.35% |
| 2021 Q2 | 594.21 Million CNY | -3.52% |
| 2021 Q3 | 613.48 Million CNY | 3.24% |
| 2021 Q1 | 615.88 Million CNY | 5.19% |
| 2021 FY | 2.42 Billion CNY | 28.13% |
| 2021 Q4 | 605.51 Million CNY | -1.3% |
| 2020 Q4 | 585.51 Million CNY | 11.52% |
| 2020 FY | 1.89 Billion CNY | -25.11% |
| 2020 Q1 | 389.61 Million CNY | -36.38% |
| 2020 Q2 | 395.68 Million CNY | 1.56% |
| 2020 Q3 | 525 Million CNY | 32.68% |
| 2019 Q3 | 612.66 Million CNY | -11.48% |
| 2019 Q4 | 612.45 Million CNY | -0.04% |
| 2019 FY | 2.53 Billion CNY | 7.2% |
| 2019 Q1 | 614.26 Million CNY | -0.77% |
| 2019 Q2 | 692.12 Million CNY | 12.68% |
| 2018 Q4 | 619.05 Million CNY | 12.83% |
| 2018 Q3 | 548.68 Million CNY | -7.99% |
| 2018 Q2 | 596.31 Million CNY | -0.19% |
| 2018 Q1 | 597.44 Million CNY | 5.98% |
| 2018 FY | 2.36 Billion CNY | 20.23% |
| 2017 Q1 | 436.99 Million CNY | -3.93% |
| 2017 FY | 1.96 Billion CNY | 16.06% |
| 2017 Q2 | 523.53 Million CNY | 19.8% |
| 2017 Q4 | 563.75 Million CNY | 28.14% |
| 2017 Q3 | 439.95 Million CNY | -15.97% |
| 2016 Q2 | 399.02 Million CNY | -4.25% |
| 2016 Q4 | 454.87 Million CNY | 7.82% |
| 2016 FY | 1.69 Billion CNY | 7.27% |
| 2016 Q1 | 416.72 Million CNY | -4.38% |
| 2016 Q3 | 421.86 Million CNY | 5.72% |
| 2015 Q2 | 427.02 Million CNY | 30.99% |
| 2015 Q1 | 325.99 Million CNY | -7.49% |
| 2015 FY | 1.57 Billion CNY | 20.57% |
| 2015 Q4 | 435.81 Million CNY | 12.06% |
| 2015 Q3 | 388.9 Million CNY | -8.93% |
| 2014 Q3 | 327.93 Million CNY | -8.97% |
| 2014 FY | 1.3 Billion CNY | 20.04% |
| 2014 Q4 | 352.4 Million CNY | 7.46% |
| 2014 Q2 | 360.26 Million CNY | 34.47% |
| 2014 Q1 | 267.91 Million CNY | -3.72% |
| 2013 FY | 1.09 Billion CNY | 22.97% |
| 2013 Q1 | 241.33 Million CNY | 1.99% |
| 2013 Q2 | 286.52 Million CNY | 18.73% |
| 2013 Q3 | 283.91 Million CNY | -0.91% |
| 2013 Q4 | 278.25 Million CNY | -1.99% |
| 2012 Q1 | 194.16 Million CNY | -0.26% |
| 2012 Q2 | 222.18 Million CNY | 14.43% |
| 2012 Q3 | 233.45 Million CNY | 5.07% |
| 2012 FY | 886.43 Million CNY | 18.09% |
| 2012 Q4 | 236.62 Million CNY | 1.36% |
| 2011 Q2 | 193.55 Million CNY | 16.47% |
| 2011 Q4 | 194.67 Million CNY | -0.78% |
| 2011 FY | 750.64 Million CNY | 17.16% |
| 2011 Q1 | 166.19 Million CNY | 0.08% |
| 2011 Q3 | 196.21 Million CNY | 1.37% |
| 2010 Q1 | 141.9 Million CNY | -0.34% |
| 2010 Q2 | 167 Million CNY | 17.69% |
| 2010 FY | 640.71 Million CNY | 16.16% |
| 2010 Q3 | 165.73 Million CNY | -0.76% |
| 2010 Q4 | 166.06 Million CNY | 0.2% |
| 2009 Q1 | 120.89 Million CNY | -9.18% |
| 2009 Q4 | 142.39 Million CNY | 0.67% |
| 2009 Q3 | 141.45 Million CNY | -3.68% |
| 2009 Q2 | 146.85 Million CNY | 21.48% |
| 2009 FY | 551.6 Million CNY | 13.9% |
| 2008 Q4 | 133.11 Million CNY | 9.39% |
| 2008 FY | 484.3 Million CNY | 19.76% |
| 2008 Q3 | 121.69 Million CNY | 0.0% |
| 2007 FY | 404.4 Million CNY | 23.71% |
| 2006 FY | 326.89 Million CNY | 0.0% |